title: Development and Validation of a Reversed-Phase High-performance Liquid Chromatography Method for Determination of Desmopressin in Chitosan Nanoparticles.
abstract: A simple isocratic reversed-phase high performance liquid chromatographic method was developed for determination of released desmopressin from chitosan nanoparticles in the in vitro media. The chromatographic separation was achieved with acetonitrile/water (25:75, v/v), in which water contained 0.1% v/v trifluoroacetic acid with pH=2.5 as mobile phase, a Chromolith(®) Performance RP-18e column (150×4.6 mm; 5 μm) kept at 40° and ultraviolet detection at 220 nm. The compound was eluted isocritically at a constant flow rate of 1.6 ml/min. The method was validated according to the International Conference on Harmonisation guidelines. The validation characteristics included accuracy, precision, linearity rang, selectivity, limit of detection, limit of quantitation and robustness. The calibration curve was linear (r>0.9999) over the concentration rang 0.5-100 μg/ml. The limit of detection and limit of quantitation in the release media were 0.05 and 0.5 μg/ml, respectively. The proposed method had an accuracy of and intra- and inter-day precision <4.2. Furthermore, to evaluate the performance of the proposed method, it was used in the analysis of desmopressin level in real samples containing chitosan nanoparticles in the in vitro media.
authors.affiliation: Department of Novel Drug Delivery Systems, Polymer Science Faculty, Iran Polymer and Petrochemical Institute, P.O. Box: 14965-115, Tehran, Iran.
authors.forename: S M
authors.initials: SM
authors.lastname: Taghizadeh
authors.forename: F
authors.initials: F
authors.lastname: Mohamadnia
authors.forename: L
authors.initials: L
authors.lastname: Adlnasab
keywords: Desmopressin; high-performance liquid chromatography; in vitro; method validation; nanoparticle
references.citation: Amino Acids. 2006 Feb;30(1):35-42
references.pmid: 16133762
references.citation: J Pharm Pharmacol. 1994 Aug;46(8):651-6
references.pmid: 7815278
references.citation: J Pharm Sci. 1988 May;77(5):405-8
references.pmid: 3411462
references.citation: Drugs. 2005;65(1):99-107; discussion 108-9
references.pmid: 15610055
references.citation: J Pharm Biomed Anal. 2004 Jun 29;35(4):921-7
references.pmid: 15193737
references.citation: J Control Release. 2001 Feb 23;70(3):375-82
references.pmid: 11182207
references.citation: J Am Vet Med Assoc. 1994 Jul 15;205(2):168-73
references.pmid: 7928567
references.citation: J Pharm Biomed Anal. 1994 Feb;12(2):221-33
references.pmid: 8003549
references.citation: Acta Pol Pharm. 2002 May-Jun;59(3):163-8
references.pmid: 12230240
references.citation: Gen Pharmacol. 1986;17(4):481-3
references.pmid: 3758654
references.citation: Pharm Res. 1993 Jan;10(1):68-74
references.pmid: 8430062
references.citation: J Control Release. 2004 Jul 7;97(3):503-11
references.pmid: 15212882
references.citation: J Pharm Sci. 1986 Nov;75(11):1085-8
references.pmid: 3102719
references.citation: Biopolymers. 2008;90(3):213
references.pmid: 18428153
references.citation: Pharm Res. 2007 Dec;24(12):2198-206
references.pmid: 17577641